Board of Directors
Gordon Tsang
Director
Mr. Tsang has been a member of the board of directors of the Company since December 31, 2022. Mr. Tsang was admitted as a solicitor in Australia and Hong Kong in May 2012 and December 2013, respectively. Mr. Tsang is currently a Partner of Stevenson, Wong & Co., specializing in corporate finance and commercial law. Mr. Tsang has served as a non-executive director of China Regenerative Medicine International Limited (Stock code: 8158), listed on The Stock Exchange of Hong Kong Limited, since January 2020. He has also served as an independent nonexecutive director of Crosstec Group Holdings Limited (Stock code: 3893) and Sterling Group Holdings Limited (Stock code: 1825), both listed on The Stock Exchange of Hong Kong Limited since September 2021. Mr. Tsang takes up the following roles of the following companies listed on The Stock Exchange of Hong Kong Limited: (i) the joint company secretary and authorized representative of Mabpharm Limited (Stock code: 2181) since May 2019; (ii) the company secretary and the authorized representative of Sunshine 100 China Holdings Limited (Stock code: 2608) since November 2019; (iii) the joint company secretary and authorized representative of Sundy Service Group Co. Limited (Stock code: 9608) since January 2021; (iv) the joint company secretary and authorized representative of 1957 & Co. (Hospitality) Limited (Stock code: 8495) since August 2022. In August 2008, Mr. Tsang obtained a Bachelor in Laws degree and a bachelor’s degree in Commerce (Accounting), both from the University of Melbourne, Australia. Mr. Tsang obtained a master in laws degree from the University of Melbourne, Australia in August 2010. Mr. Tsang obtained the Postgraduate Certificate in Laws from the City University of Hong Kong in July 2011. Mr. Tsang was selected to be a member of our board of directors due to his legal experience in business operations and his experience in serving as a director of public companies.
Sam Chung
Interim Chief Financial Officer, Director
Mr. Chung has served as our Interim Chief Financial Officer since February 2023 and director since April 2023. Mr. Chung has over 35 years of senior financial and management experience in North America and Asia across several industries, including consumer goods manufacturing, garment trading and manufacturing, natural resources, international logistics, and real estate. Since December 2013, Mr. Chung has served as the Chief Financial Officer and Chief Operations Officer of Sterling Group Holdings Limited (Stock code: 1825), our long-term vendor and largest creditor. Mr. Chung selected and collaborated with the initial public offering team, including the sponsor, underwriter, lawyers, and auditor, and successfully completed the IPO of the Sterling Group Holdings Limited on the main board of Hong Kong Stock Exchange in October 2018. Mr. Chung obtained a bachelor’s degree from Simon Fraser University, Canada in 1980 where he majored in Commerce and minored in economics. Mr. Chung obtained an MBA from the University of British Columbia, Canada in 1982 and obtained a CPA in Canada with a Public Practice Award for having the highest marks in British Columbia in Taxation and Auditing in the 1984 graduating class. Mr. Chung contributes to our management team with his wealth of experience in accounting and finance as a CFO in initial public offering fundraising, road shows, private placement and investor relations.
Governance Documents